Screening for local and regional cancer recurrence in patients curatively treated for laryngeal cancer: Definition of a high-risk group and estimation of the lead time

Head and Neck

Volumn 29, Issue 5, 2007, Pages 431-438

  Ritoe, Savitri C ^a   Verbeek, André L M ^a   Krabbe, Paul F M ^a   Kaanders, Johannes H A M ^a   Van Den Hoogen, Frank J A ^a   Marres, Henri A M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Follow up; Laryngeal cancer; Lead time; Prognostic factor; Recurrence

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CANCER SURVIVAL; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MASS SCREENING; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SMOKING; TIME FACTORS;

EID: 34248348299     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20534     Document Type: Article

References (19)

1. Visser O, Coebergh JWW, Schouten LJ, van Dijck JAAM, editors. Incidence of cancer in the Netherlands 1997. Ninth report of the Netherlands cancer registry. Association of Comprehensive Cancer Centers, 2001. ISBN 90-72175-31-x. (Dutch)
2. Dutch Cooperative Head and Neck Oncology Group. Association of Comprehensive Cancer Centers. Richtlijn Larynxcarcinoom 2000. Published by: Kwaliteitsinstituut voor de gezondheidszorg CBO, 2000. ISBN-number 90-75141-98-x. (Dutch)
3. Agthoven van M, Heule-Dieleman HAG, de Boer MF, et al. Evaluating adherence to the Dutch guideline for diagnosis, treatment and follow-up of laryngeal carcinomas. Radiother Oncol 2005;74:337-344.
4. Kaanders JHAM, Hordijk G, the Dutch Cooperative Head and Neck Oncology Group. Carcinoma of the larynx: the Dutch national guideline for diagnostics, treatment, supportive care and rehabilitation. Radiother Oncol 2002;63: 299-307.
5. Colosanto JM, Haffty BG, Wilson LD. Evaluation of local recurrence and second malignancy in patients with T1 and T2 squamous cell carcinoma of the larynx. Cancer J 2004;10:61-66.
6. Shikama N, Sasaki S, Nishikawa A, et al. Risk factors for locoregional recurrence following preoperative radiation therapy and surgery for head and neck cancer (stage II-IVB). Radiology 2003;228:789-794.
7. Haas I, Hauser U, Ganzer U. The dilemma of follow-up in head and neck cancer patients. Eur Arch Otorhinolaryngol 2001;258:177-183. Erratum in: Eur Arch Otorhinolaryngol 2002;259:227.
8. Brenner B, Marshak G, Sulkes A, Rakowsky E. Prognosis of patients with recurrent laryngeal carcinoma. Head Neck 2001;23:531-535.
9. Johansen LV, Grau C, Overgaard J. Supraglottic carcinoma: patterns of failure and salvage treatment after curatively intended radiotherapy in 410 consecutive patients. Int J Radiat Oncol Biol Phys 2002;53:948-958.
10. Johansen LV, Grau C, Overgaard J. Glottic carcinoma - patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients. Radiother Oncol 2002;63:257-267.
11. Grau JJ, Cuchi A, Traserra J, et al. Follow-up study in head and neck cancer: cure rate according to tumor location and stage. Oncology 1997;54:38-42.
12. Baatenburg de Jong R, Hermans J, Molenaar J, Briaire JJ, le Cessie S. Prediction of survival in patients with head and neck cancer. Head Neck 2001;23:718-724.
13. Straatman H, Peer PGM, Verbeek ALM. Estimating lead time and sensitivity in a screening program without estimating the incidence in the screened group. Biometrics 1997;53:217-229.
14. Van Gils CH, Otten JD, Hendriks JH, Holland R, Straatman H, Verbeek ALM. High mammographic breast density and its implications for the early detection of breast cancer. J Med Screen 1999;6:200-204.
15. Ritoe SC, Krabbe PFM, Kaanders JHAM, van de Hoogen FJA, Verbeek ALM, Marres HAM. Value of routine follow-up for patients cured of laryngeal carcinoma. Cancer 2004;101:1382-1389.
16. Ritoe SC, Bergman H, Krabbe PFM, et al. Cancer recurrence after total laryngectomy; treatment options, survival and complications. Head Neck 2006;28:383-388.
17. León X, Quer M, Orús C, del Prado Venegas M, Lopez M. Distant metastases in head and neck cancer patients who achieved loco-regional control. Head Neck 2000;22:680-686.
18. León X, Quer M, Diez S, Orús C, López-Pousa A, Burgués J. Second neoplasm in patients with head and neck cancer. Head Neck 1999;21:204-210.
19. Day NE. The assessment of lead time and length bias in the evaluation of screening programmes. Maturitas 1985; 7:51-58.